Differential regional zif268 messenger RNA expression in an escalating dose/binge model of amphetamine-induced psychosis

Neuroscience

Volumn 96, Issue 1, 2000, Pages 83-90

  Shilling, P D ^a   Kelsoe, J R ^a   Kuczenski, R ^a   Segal, D S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amphetamine; Dopamine; Dorsal striatum; Nucleus accumbens; Psychosis; zif268 mRNA

Indexed keywords

AMPHETAMINE; DOPAMINE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ABUSE; GENE EXPRESSION REGULATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PSYCHOSIS; RAT;

AMPHETAMINES; AMYGDALA; ANIMALS; CORPUS STRIATUM; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; IMMEDIATE-EARLY PROTEINS; MALE; NUCLEUS ACCUMBENS; OLFACTORY PATHWAYS; PSYCHOSES, SUBSTANCE-INDUCED; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 0033967230     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00510-2     Document Type: Article

References (48)

1. Angrist B. (1987) Clinical effects of central nervous system stimulants: a selective update. In Brain Reward Systems and Abuse (eds Engel J. and Oreland L.), pp. 109-127. Raven, New York.
2. Angrist B. (1994) Amphetamine psychosis: clinical variations of the syndrome. In Amphetamine and its Analogs: Neuropharmacology, Toxicology and Abuse (eds Cho A. K. and Segal D. S.), pp. 387-414. Academic, Orlando, FL.
3. Armony J.L., Ledoux J.E. How the brain processes emotional information. Ann. N. Y. Acad. Sci. 821:1997;259-270.
4. Barnett J.V., Segal D.S., Kuczenski R. Repeated amphetamine pretreatment alters the responsiveness of striatal dopamine-stimulated adenylate cyclase to amphetamine-induced desensitization. J. Pharmac. exp. Ther. 242:1987;40-47.
5. Chao H.M., McEwen B.S. Glucocorticoids and the expression of mRNAs for neurotrophins, their receptors and GAP-43 in the rat hippocampus. Brain Res. molec. Brain Res. 26:1994;271-276.
6. Cole A.J., Bhat R.V., Patt C., Worley P.F., Baraban J.M. D1 dopamine receptor activation of multiple transcription factor genes in rat striatum. J. Neurochem. 58:1992;1420-1426.
7. Costall B., Naylor R.J. Extrapyramidal and mesolimbic involvement with the stereotypic activity of D- and L-amphetamine. Eur. J. Pharmac. 25:1974;121-129.
8. Creese I., Iversen S.D. The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat. Psychopharmacologia. 39:1974;345-357.
9. Daunais J.B., McGinty J.F. Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs. Brain Res. molec. Brain Res. 29:1995;201-210.
10. Daunais J.B., McGinty J.F. The effects of D1 or D2 dopamine receptor blockade on zif/268 and preprodynorphin gene expression in rat forebrain following a short-term cocaine binge. Brain Res. molec. Brain Res. 35:1996;237-248.
11. Davis M., Falls W.A., Campeau S., Kim M. Fear-potentiated startle: a neural and pharmacological analysis. Behav Brain Res. 58:1993;175-198.
12. DeFranco C., Damon D.H., Endoh M., Wagner J.A. Nerve growth factor induces transcription of NGFIA through complex regulatory elements that are also sensitive to serum and phorbol 12-myristate 13-acetate. Molec. Endocr. 7:1993;365-379.
13. Drago J., Gerfen C.R., Westphal H., Steiner H. D1 dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum. Neuroscience. 74:1996;813-823.
14. Fibiger H. C. (1991) The dopamine hypotheses of schizophrenia and mood disorders: contradictions and speculations. In The Mesolimbic Dopamine System: From Motivation to Action (eds Willner P. and Scheel-Kruger J.), pp. 620-637. John Wiley, New York.
15. Fischman M.W., Schuster C.R. Tolerance development to chronic methamphetamine intoxication in the rhesus monkey. Pharmac. Biochem. Behav. 2:1974;503-508.
16. Fischman M.W., Schuster C.R. Long-term behavioral changes in the rhesus monkey after multiple daily injections of D-methylamphetamine. J. Pharmac. exp. Ther. 201:1977;593-605.
17. Gawin F. H. and Kalsa M. E. (1996) Sensitization and "street" stimulant addiction. In NIDA Research Monograph Series (ed. Majewska M. D.), pp. 224-250. U.S. Government Printing Office, Washington, DC.
18. Gerfen C.R., Keefe K.A., Gauda E.B. D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J. Neurosci. 15:1995;8167-8176.
19. Kilts C.D., Anderson C.M., Ely T.D., Mailman R.B. The biochemistry and pharmacology of mesoamygdaloid dopamine neurons. Ann. N. Y. Acad. Sci. 537:1988;173-187.
20. Konradi C., Leveque J.C., Hyman S.E. Amphetamine- and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J. Neurosci. 16:1997;4231-4239.
21. Kuczenski R., Segal D.S. An escalating dose/multiple high-dose binge pattern of amphetamine administration results in differential changes in the extracellular dopamine response profiles in caudate-putamen and nucleus accumbens. J. Neurosci. 17:1997;4441-4447.
22. Ledoux J.E., Cicchetti P., Xagoraris A., Romanski L.M. The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning. J. Neurosci. 10:1990;1062-1069.
23. Lerea L.S., Carlson N.G., McNamara J.O. N-Methyl-D-aspartate receptors activate transcription of c-fos and NGFI-A by distinct phospholipase A2-requiring intracellular signaling pathways. Molec. Pharmac. 47:1995;1119-1125.
24. McDonald A.J. Cytoarchitecture of the central amygdaloid nucleus of the rat. J. comp. Neurol. 208:1982;401-418.
25. Moratalla R., Robertson H.A., Graybiel A.M. Dynamic regulation of NGFI-A (zif268, egr1) gene expression in the striatum. J. Neurosci. 12:1992;2609-2622.
26. Muller J., Corodimas K.P., Fridel Z., Ledoux J.E. Functional inactivation of the lateral and basal nuclei of the amygdala by muscimol infusion prevents fear conditioning to an explicit conditioned stimulus and to contextual stimuli. Behav. Neurosci. 111:1997;683-691.
27. Paxinos G. and Watson C. (1997) The Rat Brain in Stereotaxic Coordinates. Academic, New York.
28. Persico A.M., Schindler C.W., O'Hara B.F., Brannock M.T., Uhl G.R. Brain transcription factor expression: effects of acute and chronic amphetamine and injection stress. Brain Res. molec. Brain Res. 20:1993;91-100.
29. Rebec G.V., Segal D.S. Apparent tolerance to some aspects of amphetamine stereotypy with long-term treatment. Pharmac. Biochem. Behav. 13:1980;793-797.
30. Roberts-Lewis J.M., Roseboom P.H., Iwaniec L.M., Gnegy M.E. Differential down-regulation of D1-stimulated adenylate cyclase activity in rat forebrain after in vivo amphetamine treatments. J. Neurosci. 6:1986;2245-2251.
31. Sananes C.B., Davis M. N-Methyl-D-aspartate lesions of the lateral and basolateral nuclei of the amygdala block fear-potentiated startle and shock sensitization of startle. Behav. Neurosci. 106:1992;72-80.
32. Schmidt C.J., Gehlert D.R., Peat M.A., Sonsalla P.K., Hanson G.R., Wamsley J.K., Gibb J.W. Studies on the mechanism of tolerance to methamphetamine. Brain Res. 343:1985;305-313.
33. Schuster C. R. and Fischman M. W. (1996) Amphetamine toxicity: behavioral and neuropathological indexes. In Current Status of Behavioral Pharmacology, pp. 1845-1851. ASPET, Rockville, MD.
34. Segal D.S., Kuczenski R. Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization. J. Pharmac. exp. Ther. 282:1997;561-573.
35. Segal D.S., Kuczenski R. An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics. J. Neurosci. 17:1997;2551-2566.
36. Segal D. S. and Schuckit M. A. (1983) Animal models of stimulant-induced psychosis. In Stimulants: Neurochemical, Behavioral, and Clinical Perspectives (ed. Creese I.), pp. 131-167. Raven, New York.
37. Sessions G.R., Meyerhoff J.L., Kant G.J., Koob G.F. Effects of lesions of the ventral medial tegmentum on locomotor activity, biogenic amines and responses to amphetamine in rats. Pharmac. Biochem. Behav. 12:1980;603-608.
38. Sheng M., Greenberg M.E. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron. 4:1990;477-485.
39. Shilling P.D., Kelsoe J.R., Segal D.S. Hippocampal glucocorticoid receptor mRNA is up-regulated by acute and down-regulated by chronic amphetamine treatment. Brain Res. molec. Brain Res. 38:1996;185-189.
40. Simon H., Taghzouti K., Gozlan H., Studler J.M., Louilot A., Herve D., Glowinski J., Tassin J.P., Le Moal M. Lesion of dopaminergic terminals in the amygdala produces enhanced locomotor response to D-amphetamine and opposite changes in dopaminergic activity in prefrontal cortex and nucleus accumbens. Brain Res. 447:1988;335-340.
41. Swerdlow N.R., Vaccarino F.J., Amalric M., Koob G.F. The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings. Pharmac. Biochem. Behav. 25:1986;233-248.
42. Wang J.Q., Daunais J.B., McGinty J.F. NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Synapse. 18:1994;343-353.
43. Wang J.Q., Daunais J.B., McGinty J.F. Role of kainate/AMPA receptors in induction of striatal zif/268 and preprodynorphin mRNA by a single injection of amphetamine. Brain Res. molec. Brain Res. 27:1994;118-126.
44. Wang J.Q., McGinty J.F. Alterations in striatal zif/268, preprodynorphin and preproenkephalin mRNA expression induced by repeated amphetamine administration in rats. Brain Res. 673:1995;262-274.
45. Wang J.Q., McGinty J.F. Acute methamphetamine-induced zif/268, preprodynorphin, and preproenkephalin mRNA expression in rat striatum depends on activation of NMDA and kainate/AMPA receptors. Brain Res. Bull. 39:1996;349-357.
46. Wang J.Q., Smith A.J., McGinty J.F. A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and preprodynorphin messenger RNA expression in rat forebrain. Neuroscience. 68:1995;83-95.
47. Wolf M.E., Dahlin S.L., Hu X.T., Xue C.J., White K. Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonists. Neuroscience. 69:1995;417-439.
48. Worley P.F., Christy B.A., Nakabeppu Y., Bhat R.V., Cole A.J., Baraban J.M. Constitutive expression of zif268 in neocortex is regulated by synaptic activity. Proc. natn. Acad. Sci. U.S.A. 88:1991;5106-5110.